Company / Interest Expense per Share
KIORA PHARMACEUTICALS INC Interest Expense per Share History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.00
FY2021
5-year range
$0.00 / $0.00
FY2017-FY2021
Trend
+845.2%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense per Share changed +845% YoY in FY2021, a notable deviation from the 5-year average annual change of +243%.
Based on SEC 10-K filings.
0.00 in FY2021 with a 5-year CAGR of -68.7%.
Increased from $0.00 to $0.00 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +120.4%
- 5-Year CAGR
- -68.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, interest expense per share increased 845.2% year-over-year.
- Peak interest expense per share was recorded in FY2016.
- Lowest interest expense per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -5.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2021 | $0.00 | +845.2% |
| FY2020 | $0.00 | -76.7% |
| FY2019 | $0.00 | +386.1% |
| FY2018 | $0.00 | +159.4% |
| FY2017 | $0.00 | -100.0% |
| FY2016 | $0.25 | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026